id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2025-0081-0004,DEA,DEA-2025-0081,SIGNED - OASH to DEA Ltr 3-MeO PCP.VAS,Supporting & Related Material,,2025-06-10T04:00:00Z,2025,6,,,2025-06-10T17:28:14Z,,0,0,09000064b8ddfd9d
DEA-2025-0081-0002,DEA,DEA-2025-0081,DEA1146 8 Factor 3-MeO-PCP,Supporting & Related Material,,2025-06-10T04:00:00Z,2025,6,,,2025-06-10T17:27:40Z,,0,0,09000064b8ddfd9b
DEA-2025-0081-0003,DEA,DEA-2025-0081,HHS 8FA 3-MeO-PCP Review,Supporting & Related Material,,2025-06-10T04:00:00Z,2025,6,,,2025-06-10T17:27:57Z,,0,0,09000064b8ddfd9c
DEA-2025-0081-0001,DEA,DEA-2025-0081,Schedules of Controlled Substances: Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I,Proposed Rule,,2025-06-10T00:00:00Z,2025,6,2025-06-10T00:00:00Z,2025-07-11T03:59:59Z,2025-07-04T09:00:31Z,2025-10503,0,0,09000064b8ded153